“By adding immunotherapy to chemotherapy and radiotherapy, we may be able to spare patients the physical and psychological ...

What Is It, and Why Does It Matter? Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) are prescription immunotherapy medicines used to help the body's immune system ...

Durvalumab shows promising results in trial led by London-based Institute of Cancer Research ...

For the thousands of Americans living with non-muscle invasive bladder cancer (NMIBC), a newly approved therapy may provide an alternative to bladder removal surgery even after standard treatment ...

An eight-year Indian clinical trial shows that radiation therapy after bladder removal surgery can significantly reduce cancer recurrence, offering a more affordable alternative to costly ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

The Food and Drug Administration approved Merck's Keytruda in combination with Padcev to treat certain adults with muscle invasive bladder cancer (MIBC). The FDA said Friday it has approved the drug ...

Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...

Aleksandar Alchev is a Director of Business Development at Minnesota Urology, overseeing the practice’s In-Office Dispensary, Prostate Cancer Navigation, Cancer Center Operations, and Men’s Health ...

After partnering with Depend last year following his bladder cancer surgery, Colorado head coach Deion Sanders brought his story to life in his first commercial for the company. Sanders starred in ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...